Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larroche

Showing results (151-160 of 177) with videos related to

Pageof 18
Sort By:
British Journal of Haematology|October 11, 2011
Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patientsDelphine Gobert, James B Bussel, Charlotte Cunningham-Rundles, et al.
Rheumatology (Oxford, England)|December 19, 2018
Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?Céline Anquetil, Eric Hachulla, François Machuron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2009
Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defectMarion Malphettes, Laurence Gérard, Maryvonnick Carmagnat, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 25, 2024
Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological DataYann Nguyen, Maxime Beydon, Jacques-Eric Gottenberg, et al.
Rheumatology (Oxford, England)|August 12, 2020
Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESSRenaud Felten, Margherita Giannini, Benoit Nespola, et al.
Annals of the Rheumatic Diseases|November 20, 2004
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseasesJ-E Gottenberg, L Guillevin, O Lambotte, et al.
Arthritis and Rheumatism|October 15, 2003
Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature reviewRobin Dhote, Jeanne Simon, Thomas Papo, et al.
American Journal of Hematology|June 16, 2026
The IL-10/IL-6 Ratio and the Risk Score: Two Cytokines-Based Predictors for Malignancy-Associated Hemophagocytic Lymphohistiocytosis in Adults (M-HLHa)Coralie Bloch, Stephanie Chhun, Nanthara Sritharan, et al.
JAMA|July 17, 2014
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trialJacques-Eric Gottenberg, Philippe Ravaud, Xavier Puéchal, et al.
The Lancet. Rheumatology|March 4, 2024
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohortsYann Nguyen, Gaëtane Nocturne, Julien Henry, et al.
Pageof 18

Showing results (151-160 of 177) with videos related to

Sort By:
Pageof 18
British Journal of Haematology|October 11, 2011
Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patientsDelphine Gobert, James B Bussel, Charlotte Cunningham-Rundles, et al.
Rheumatology (Oxford, England)|December 19, 2018
Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?Céline Anquetil, Eric Hachulla, François Machuron, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2009
Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defectMarion Malphettes, Laurence Gérard, Maryvonnick Carmagnat, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 25, 2024
Distinct Pathophysiologic Pathways Support Stratification of Sjögren's Disease Based on Symptoms, Clinical, and Routine Biological DataYann Nguyen, Maxime Beydon, Jacques-Eric Gottenberg, et al.
Rheumatology (Oxford, England)|August 12, 2020
Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESSRenaud Felten, Margherita Giannini, Benoit Nespola, et al.
Annals of the Rheumatic Diseases|November 20, 2004
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseasesJ-E Gottenberg, L Guillevin, O Lambotte, et al.
Arthritis and Rheumatism|October 15, 2003
Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature reviewRobin Dhote, Jeanne Simon, Thomas Papo, et al.
American Journal of Hematology|June 16, 2026
The IL-10/IL-6 Ratio and the Risk Score: Two Cytokines-Based Predictors for Malignancy-Associated Hemophagocytic Lymphohistiocytosis in Adults (M-HLHa)Coralie Bloch, Stephanie Chhun, Nanthara Sritharan, et al.
JAMA|July 17, 2014
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trialJacques-Eric Gottenberg, Philippe Ravaud, Xavier Puéchal, et al.
The Lancet. Rheumatology|March 4, 2024
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohortsYann Nguyen, Gaëtane Nocturne, Julien Henry, et al.
Pageof 18